- Prongay,A.J., Guo,Z., Yao,N., Pichardo,J., Fischmann,T., Strickland,C., Myers,J., Jr., Weber,P.C., Beyer,B.M., Ingram,R., Hong,Z., Prosise,W.W., Ramanathan,L., Taremi,S.S., Yarosh-Tomaine,T., Zhang,R., Senior,M., Yang,R.S., Malcolm,B., Arasappan,A., Bennett,F., Bogen,S.L., Chen,K., Jao,E., Liu,Y.T., Lovey,R.G., Saksena,A.K., Venkatraman,S., Girijavallabhan,V., Njoroge,F.G. and Madison,V.<br>Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (SCH 503034) II. Key steps in structure-based optimization<br>J Med Chem (2007) 50, 2310-2318. PubMed Europe PubMed DOI I
2007
